annual total liabilities:
$111.33M+$25.03M(+29.00%)Summary
- As of today (September 14, 2025), LGND annual total liabilities is $111.33 million, with the most recent change of +$25.03 million (+29.00%) on December 31, 2024.
- During the last 3 years, LGND annual total liabilities has fallen by -$365.10 million (-76.63%).
- LGND annual total liabilities is now -85.19% below its all-time high of $751.86 million, reached on December 31, 2018.
Performance
LGND Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$120.08M+$10.17M(+9.26%)Summary
- As of today (September 14, 2025), LGND quarterly total liabilities is $120.08 million, with the most recent change of +$10.17 million (+9.26%) on June 30, 2025.
- Over the past year, LGND quarterly total liabilities has increased by +$28.87 million (+31.65%).
- LGND quarterly total liabilities is now -91.46% below its all-time high of $1.41 billion, reached on September 30, 2018.
Performance
LGND quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LGND Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.0% | +31.6% |
| 3 y3 years | -76.6% | -56.2% |
| 5 y5 years | -84.7% | -78.1% |
LGND Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.6% | +29.0% | -56.2% | +39.1% |
| 5 y | 5-year | -84.7% | +29.0% | -81.6% | +39.1% |
| alltime | all time | -85.2% | +2121.6% | -91.5% | >+9999.0% |
LGND Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $120.08M(+9.3%) |
| Mar 2025 | - | $109.90M(-1.3%) |
| Dec 2024 | $111.33M(+29.0%) | $111.33M(-2.1%) |
| Sep 2024 | - | $113.69M(+24.6%) |
| Jun 2024 | - | $91.21M(-15.0%) |
| Mar 2024 | - | $107.35M(+24.4%) |
| Dec 2023 | $86.30M(-47.8%) | $86.30M(-14.8%) |
| Sep 2023 | - | $101.33M(+8.7%) |
| Jun 2023 | - | $93.21M(-43.4%) |
| Mar 2023 | - | $164.76M(-0.3%) |
| Dec 2022 | $165.18M(-65.3%) | $165.18M(-29.5%) |
| Sep 2022 | - | $234.31M(-14.5%) |
| Jun 2022 | - | $273.92M(-12.2%) |
| Mar 2022 | - | $311.99M(-34.5%) |
| Dec 2021 | $476.43M(-27.0%) | $476.43M(+3.2%) |
| Sep 2021 | - | $461.59M(-1.7%) |
| Jun 2021 | - | $469.77M(-14.5%) |
| Mar 2021 | - | $549.28M(-15.9%) |
| Dec 2020 | $652.76M(-10.3%) | $652.76M(+18.8%) |
| Sep 2020 | - | $549.63M(+0.3%) |
| Jun 2020 | - | $547.93M(+4.6%) |
| Mar 2020 | - | $524.02M(-28.0%) |
| Dec 2019 | $727.68M(-3.2%) | $727.68M(+4.4%) |
| Sep 2019 | - | $696.89M(-8.3%) |
| Jun 2019 | - | $760.38M(-8.8%) |
| Mar 2019 | - | $834.01M(+10.9%) |
| Dec 2018 | $751.86M(+132.9%) | $751.86M(-46.5%) |
| Sep 2018 | - | $1.41B(+13.5%) |
| Jun 2018 | - | $1.24B(+352.7%) |
| Mar 2018 | - | $273.57M(-19.9%) |
| Dec 2017 | $322.86M(+24.0%) | $341.72M(+31.9%) |
| Sep 2017 | - | $259.17M(+1.7%) |
| Jun 2017 | - | $254.91M(-1.2%) |
| Mar 2017 | - | $257.89M(-0.9%) |
| Dec 2016 | $260.30M(-2.1%) | $260.30M(-0.9%) |
| Sep 2016 | - | $262.61M(+1.2%) |
| Jun 2016 | - | $259.56M(+17.3%) |
| Mar 2016 | - | $221.36M(-16.7%) |
| Dec 2015 | $265.78M(+13.8%) | $265.78M(+15.8%) |
| Sep 2015 | - | $229.52M(-2.6%) |
| Jun 2015 | - | $235.71M(+2.1%) |
| Mar 2015 | - | $230.83M(-1.2%) |
| Dec 2014 | $233.62M(+324.0%) | $233.62M(+1.8%) |
| Sep 2014 | - | $229.50M(+524.3%) |
| Jun 2014 | - | $36.76M(-9.2%) |
| Mar 2014 | - | $40.47M(-26.6%) |
| Dec 2013 | $55.10M(-29.2%) | $55.10M(-3.1%) |
| Sep 2013 | - | $56.86M(-5.7%) |
| Jun 2013 | - | $60.30M(-11.0%) |
| Mar 2013 | - | $67.77M(-12.9%) |
| Dec 2012 | $77.78M(-25.3%) | $77.78M(+2.0%) |
| Sep 2012 | - | $76.27M(-11.5%) |
| Jun 2012 | - | $86.14M(-6.9%) |
| Mar 2012 | - | $92.56M(-11.1%) |
| Dec 2011 | $104.05M(+44.4%) | $104.05M(>+9900.0%) |
| Sep 2011 | - | $0.00(-100.0%) |
| Jun 2011 | - | $113.76M(-5.8%) |
| Mar 2011 | - | $120.80M(+67.6%) |
| Dec 2010 | $72.06M(-44.4%) | $72.06M(-18.7%) |
| Sep 2010 | - | $88.60M(-3.2%) |
| Jun 2010 | - | $91.53M(-25.7%) |
| Mar 2010 | - | $123.13M(-5.1%) |
| Dec 2009 | $129.72M | $129.72M(+9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | $118.24M(-11.2%) |
| Jun 2009 | - | $133.09M(-6.2%) |
| Mar 2009 | - | $141.94M(-16.2%) |
| Dec 2008 | $169.47M(+28.6%) | $169.47M(+27.5%) |
| Sep 2008 | - | $132.89M(+3.3%) |
| Jun 2008 | - | $128.66M(-0.6%) |
| Mar 2008 | - | $129.39M(-1.8%) |
| Dec 2007 | $131.82M(-54.0%) | $131.82M(-23.8%) |
| Sep 2007 | - | $172.89M(-5.0%) |
| Jun 2007 | - | $181.90M(-60.0%) |
| Mar 2007 | - | $455.06M(+58.9%) |
| Dec 2006 | $286.36M(-30.6%) | $286.36M(-39.2%) |
| Sep 2006 | - | $470.71M(-8.1%) |
| Jun 2006 | - | $512.09M(+2.3%) |
| Mar 2006 | - | $500.70M(+21.3%) |
| Dec 2005 | $412.69M(+4.4%) | $412.69M(+2.6%) |
| Sep 2005 | - | $402.12M(+2.6%) |
| Jun 2005 | - | $391.77M(-0.8%) |
| Mar 2005 | - | $394.86M(-0.1%) |
| Dec 2004 | $395.44M(+71.5%) | $395.44M(+59.6%) |
| Sep 2004 | - | $247.70M(+4.4%) |
| Jun 2004 | - | $237.32M(+1.5%) |
| Mar 2004 | - | $233.82M(+1.4%) |
| Dec 2003 | $230.53M(+17.3%) | $230.53M(+9.7%) |
| Sep 2003 | - | $210.20M(+5.2%) |
| Jun 2003 | - | $199.88M(-1.6%) |
| Mar 2003 | - | $203.15M(+3.3%) |
| Dec 2002 | $196.59M(+12.1%) | $196.59M(+426.2%) |
| Sep 2002 | - | $37.36M(-8.1%) |
| Jun 2002 | - | $40.65M(-53.8%) |
| Mar 2002 | - | $87.88M(-49.9%) |
| Dec 2001 | $175.35M(+4.0%) | $175.35M(+3.7%) |
| Sep 2001 | - | $169.14M(-0.7%) |
| Jun 2001 | - | $170.33M(+3.6%) |
| Mar 2001 | - | $164.45M(-2.4%) |
| Dec 2000 | $168.55M(+5.2%) | $168.55M(+16.0%) |
| Sep 2000 | - | $145.35M(-0.3%) |
| Jun 2000 | - | $145.80M(+2.5%) |
| Mar 2000 | - | $142.20M(-11.3%) |
| Dec 1999 | $160.24M(-4.3%) | $160.24M(-9.3%) |
| Sep 1999 | - | $176.70M(+15.1%) |
| Jun 1999 | - | $153.57M(+1.6%) |
| Mar 1999 | - | $151.09M(-9.7%) |
| Dec 1998 | $167.38M(+129.1%) | $167.38M(+41.3%) |
| Sep 1998 | - | $118.43M(+72.8%) |
| Jun 1998 | - | $68.53M(+2.8%) |
| Mar 1998 | - | $66.64M(-8.8%) |
| Dec 1997 | $73.07M(+8.0%) | $73.10M(+18.3%) |
| Sep 1997 | - | $61.80M(-4.5%) |
| Jun 1997 | - | $64.70M(+1.4%) |
| Mar 1997 | - | $63.80M(-5.6%) |
| Dec 1996 | $67.68M(+3.3%) | $67.60M(+14.4%) |
| Sep 1996 | - | $59.10M(-7.7%) |
| Jun 1996 | - | $64.00M(+0.9%) |
| Mar 1996 | - | $63.40M(-3.2%) |
| Dec 1995 | $65.52M(+221.8%) | $65.50M(+8.3%) |
| Sep 1995 | - | $60.50M(+216.8%) |
| Mar 1995 | - | $19.10M(-6.4%) |
| Dec 1994 | $20.36M(+159.2%) | $20.40M(+5.2%) |
| Sep 1994 | - | $19.40M(+158.7%) |
| Jun 1994 | - | $7.50M(+2.7%) |
| Mar 1994 | - | $7.30M |
| Dec 1993 | $7.86M(+56.8%) | - |
| Dec 1992 | $5.01M | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual total liabilities?
- What is the all time high annual total liabilities for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual total liabilities year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly total liabilities?
- What is the all time high quarterly total liabilities for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly total liabilities year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual total liabilities?
The current annual total liabilities of LGND is $111.33M
What is the all time high annual total liabilities for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual total liabilities is $751.86M
What is Ligand Pharmaceuticals Incorporated annual total liabilities year-on-year change?
Over the past year, LGND annual total liabilities has changed by +$25.03M (+29.00%)
What is Ligand Pharmaceuticals Incorporated quarterly total liabilities?
The current quarterly total liabilities of LGND is $120.08M
What is the all time high quarterly total liabilities for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly total liabilities is $1.41B
What is Ligand Pharmaceuticals Incorporated quarterly total liabilities year-on-year change?
Over the past year, LGND quarterly total liabilities has changed by +$28.87M (+31.65%)